From October 1, 2023 to December 31, 2023, the company has repurchased 811,384 shares, representing 1.29% for $99.79 million. With this, the company has completed the repurchase of 9,991,026 shares, representing 16.77% for $1,358.79 million under the buyback announced on November 8, 2016.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
109.6 USD | -3.09% | -0.35% | -10.87% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.87% | 6.91B | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- JAZZ Stock
- News Jazz Pharmaceuticals plc
- Tranche Update on Jazz Pharmaceuticals plc's Equity Buyback Plan announced on November 8, 2016.